Clinical trial / 2013
Ginger supplementation improved insulin sensitivity and lipid markers in type 2 diabetes
In a double-blind trial, 64 patients with type 2 diabetes received 2 g daily of ginger or placebo for 2 months. Ginger supplementation significantly decreased insulin levels (11.0 vs 12.1), LDL cholesterol (67.8 vs 89.2), triglycerides (127.7 vs 128.2), and HOMA index (3.9 vs 4.5), while increasing QUICKI (0.313 vs 0.308). Fasting glucose, total cholesterol, HDL cholesterol, and HbA1c did not change significantly between groups.
- Study type
- Randomized double-blind placebo-controlled trial
- Who was studied
- 64 patients with type 2 diabetes
- What was measured
- Glycemic indices, insulin sensitivity, and lipid profile
THE PAPER
Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients.
Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SE. Int J Food Sci Nutr, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.